title: Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.
abstract: Neurological disease associated with lentiviral infection occurs mainly as a consequence of primary replication of the virus or a combination of the virus infection and replication of opportunistic pathogens in the central nervous system. Recent studies have shown that whereas the disease can be caused by CCR5 tropic viruses alone, its induction by CXCR4 (X4) tropic viruses occurred usually in association with infections caused by opportunistic pathogens and in the presence of a Th2 cytokine, interleukin (IL)-4.(1,2) Further, X4-mediated neurological disease developed preferentially in rhesus compared to pig-tailed macaques. Because macrophages are the target cells for lentiviral infection in the brain and because macrophage chemoattractant protein (MCP)-1 is one of the major chemokines that is closely associated with acquired immune deficiency syndrome (AIDS) dementia, we tested for correlations between MCP-1 production and virus tropism in macrophages from the two species of macaques. The studies showed that the higher susceptibility of rhesus macaques to X4 virus-mediated encephalitis correlated with heightened production of virus and MCP-1 in cultured macrophages from this species and that these effects were further enhanced with treatment with IL-4. However, the latter effect was restricted to macrophages infected with X4 viruses. IL-4 may therefore be a basic requirement for X4 viruses to cause central nervous system disease.
authors.affiliation: Department of Microbiology, Immunology, and Molecular Genetics, University of Kansas Medical Center, Kansas City 66160, USA.
authors.forename: Andrey
authors.initials: A
authors.lastname: Hicks
authors.forename: Raghava
authors.initials: R
authors.lastname: Potula
authors.forename: Yong Jun
authors.initials: YJ
authors.lastname: Sui
authors.forename: Francois
authors.initials: F
authors.lastname: Villinger
authors.forename: David
authors.initials: D
authors.lastname: Pinson
authors.forename: Istvan
authors.initials: I
authors.lastname: Adany
authors.forename: Zhuang
authors.initials: Z
authors.lastname: Li
authors.forename: Chloe
authors.initials: C
authors.lastname: Long
authors.forename: Paul
authors.initials: P
authors.lastname: Cheney
authors.forename: Joanne
authors.initials: J
authors.lastname: Marcario
authors.forename: Francis
authors.initials: F
authors.lastname: Novembre
authors.forename: Niklaus
authors.initials: N
authors.lastname: Mueller
authors.forename: Anil
authors.initials: A
authors.lastname: Kumar
authors.forename: Eugene
authors.initials: E
authors.lastname: Major
authors.forename: Opendra
authors.initials: O
authors.lastname: Narayan
authors.forename: Shilpa
authors.initials: S
authors.lastname: Buch
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D002478:Cells, Cultured; D018932:Chemokine CCL2 / Q000096:biosynthesis*; D015847:Interleukin-4 / Q000494:pharmacology*; D016086:Lentivirus / Q000502:physiology; D016180:Lentivirus Infections / Q000378:metabolism* / Q000473:pathology; D008251:Macaca; D008264:Macrophages / Q000378:metabolism* / Q000821:virology*; D019713:Receptors, CCR5 / Q000378:metabolism*; D019718:Receptors, CXCR4 / Q000378:metabolism*; D014779:Virus Replication / Q000187:drug effects
chemical_list: D000276:Adjuvants, Immunologic; D018932:Chemokine CCL2; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D015847:Interleukin-4